CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxic

Author:

Guo Ju1,Zhou Qiang2,Huang Wei,Xiong Jing2,Guo Biao2,Wang Xinghuan3ORCID

Affiliation:

1. The First Affiliated Hospital of Nanchang University

2. First Affiliated Hospital of Nanchang University

3. Zhongnan Hospital of Wuhan University

Abstract

Abstract Hypoxia is an essential feature of solid tumors. The regulatory network behind tumor cells in response to hypoxia environment is not completely comprehend. We ascertained the biochemical role of cell cycle division-related gene 8 (CDCA8) in bladder cancer (Bca) survival under hypoxia environment. In current study we revealed the expression of CDCA8 was considerably upraised in BCa. High expression level of CDCA8 was positive related with advanced Bca stage, advanced Bca stage grade and poor survival. Increased CDCA8 expression was decisive for Bca cells to survive in a hypoxic condition. CDCA8 enhanced the stabilization of HIF1α by competitively binding to AKT with PTEN and alleviating PTEN suppression to activate AKT phosphorylation, while HIF1α transcriptionally promote CDCA8 transcription, thus forming a positive feedback loop in Bca adaptation to oxygen-deficient environment. Collectively, CDCA8 promotes Bca survival under hypoxic environment by activating AKT/GSK3β signaling pathway and heightening the stabilization of HIF1α. CDCA8 is critical for Bca to adapt to oxygen deprivation and may provide a novel thinking for Bca treatment.

Publisher

Research Square Platform LLC

Reference38 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2021.

2. Bladder cancer;Braud F;Crit Rev Oncol Hematol,2002

3. NCCN Guidelines(R) Insights: Bladder Cancer, Version 2.2022;Flaig TW;J Natl Compr Canc Netw,2022

4. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure;Stein JP;World J Urol,2006

5. Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain;Bui BP;Cancers (Basel),2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3